Evidence map›Paper›PMID 35772213›Full record

ArticleBiochemical and biophysical research communications2022

SARS-CoV-2 Spike mutations modify the interaction between virus Spike and human ACE2 receptors.

Pushpendra Mani Mishra, Farhan Anjum, Vladimir N Uversky, Chayan Kanti Nandi

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Exploring protein functions from structural flexibility using CABS-flex modeling.Protein science : a publication of the Protein Society · 2024
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Pushpendra Mani MishraSchool of Basic Sciences, Indian Institute of Technology, Mandi, HP, 175005, India; Advanced Material Research Centre, Indian Institute of Technology, Mandi, HP, 175005, India; Bio-X Centre, Indian Institute of Technology, Mandi, HP, 175005, India.
Farhan AnjumSchool of Basic Sciences, Indian Institute of Technology, Mandi, HP, 175005, India; Advanced Material Research Centre, Indian Institute of Technology, Mandi, HP, 175005, India; Bio-X Centre, Indian Institute of Technology, Mandi, HP, 175005, India.
Vladimir N UverskyDepartment of Molecular Medicine and Byrd Alzheimer's Research Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, USA. Electronic address: vuversky@health.usf.edu.
Chayan Kanti NandiSchool of Basic Sciences, Indian Institute of Technology, Mandi, HP, 175005, India; Advanced Material Research Centre, Indian Institute of Technology, Mandi, HP, 175005, India; Bio-X Centre, Indian Institute of Technology, Mandi, HP, 175005, India. Electronic address: chayan@iitmandi.ac.in.
Indian Institute of Technology Mandi · INUniversity of South Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The high mutability of the SARS-CoV-2 virus is a growing concern among scientific communities and health professionals since it brings the effectiveness of repurposed drugs and vaccines for COVID-19 into question. Although the mutational investigation of the Spike protein of the SARS-CoV-2 virus has been confirmed by many different researchers, there is no thorough investigation carried out at the interacting region to reveal the mutational status and its associated severity. All the energetically favorable mutations and their detailed analytical features that could impact the infection severity of the SARS-CoV-2 virus need to be identified. Therefore, we have thoroughly investigated the most important site of the SARS-CoV-2 virus, which is the interface region (Residue 417-505) of the virus Spike that interacts with the human ACE2 receptor. Further, we have utilized molecular dynamic simulation to observe the relative stability of the Spike protein with partner ACE2, as a consequence of these mutations. In our study, we have identified 52 energetically favorable Spike mutations at the interface while binding to ACE2, of which only 36 significantly enhance the stabilization of the Spike-ACE2 complex. The stability order and molecular interactions of these mutations were also identified. The highest stabilizing mutation V503D confirmed in our study is also known for neutralization resistance.

Indexed as

COVID-19SARS-CoV-2Angiotensin-Converting Enzyme 2COVID-19 VaccinesHumansMolecular Dynamics SimulationMutationPeptidyl-Dipeptidase AProtein BindingReceptors, VirusSpike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2COVID-19 VaccinesPeptidyl-Dipeptidase AReceptors, VirusSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2COVID-19Interface residuesMutationSARS-CoV-2Spike protein

Identifiers

PMID35772213
PMCPMC9221686
OpenAlexW4283320962

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.